Abstract
Summary
The Propofol API is an intravenous, short acting anesthetic with rapid onset of action used in the induction and maintenance of anesthesia.
The global Propofol market is projected to reach US$ 22 million by 2030 from an estimated US$ 18 million in 2024, at a CAGR of 3.6% during 2024 and 2030.
Bachem is the world's largest manufacturers of Propofol, with a market share of nearly 50%, other major manufacturers include Curia and SI Group. Europe dominates the global propofol market with market share 60% in production, followed by China and India. In terms of product types, propofol with purity below 99.5% occupied more than 99% of the share, and the rest is propofol with purity over 99.5%. In terms of product application, propofol injection emulsion occupies for a share of 65%, and propofol mct/lct injection occupies for a share of 35%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Propofol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Propofol.
The Propofol market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Propofol market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Propofol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Segment by Type
Purity above 99.5%
Purity below 99.5%
Segment by Application
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Propofol in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Propofol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Propofol sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
The global Propofol market is projected to reach US$ 22 million by 2030 from an estimated US$ 18 million in 2024, at a CAGR of 3.6% during 2024 and 2030.
Bachem is the world's largest manufacturers of Propofol, with a market share of nearly 50%, other major manufacturers include Curia and SI Group. Europe dominates the global propofol market with market share 60% in production, followed by China and India. In terms of product types, propofol with purity below 99.5% occupied more than 99% of the share, and the rest is propofol with purity over 99.5%. In terms of product application, propofol injection emulsion occupies for a share of 65%, and propofol mct/lct injection occupies for a share of 35%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Propofol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Propofol.
The Propofol market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Propofol market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Propofol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Segment by Type
Purity above 99.5%
Purity below 99.5%
Segment by Application
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Propofol in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Propofol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Propofol sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Propofol Product Introduction
1.2 Market by Type
1.2.1 Global Propofol Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Purity above 99.5%
1.2.3 Purity below 99.5%
1.3 Market by Application
1.3.1 Global Propofol Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Propofol Injectable Emulsion
1.3.3 Propofol MCT/LCT Injectable Emulsion
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Propofol Market Size Estimates and Forecasts
2.1.1 Global Propofol Revenue 2019-2030
2.1.2 Global Propofol Sales 2019-2030
2.2 Propofol Market Size by Region: 2023 Versus 2030
2.3 Propofol Sales by Region (2019-2030)
2.3.1 Global Propofol Sales by Region: 2019-2024
2.3.2 Global Propofol Sales Forecast by Region (2025-2030)
2.3.3 Global Propofol Sales Market Share by Region (2019-2030)
2.4 Propofol Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Propofol Revenue by Region: 2019-2024
2.4.2 Global Propofol Revenue Forecast by Region (2025-2030)
2.4.3 Global Propofol Revenue Market Share by Region (2019-2030)
3 Global Propofol by Manufacturers
3.1 Global Top Propofol Manufacturers by Sales
3.1.1 Global Propofol Sales by Manufacturer (2019-2024)
3.1.2 Global Propofol Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Propofol Manufacturers by Revenue
3.2.1 Global Propofol Revenue by Manufacturer (2019-2024)
3.2.2 Global Propofol Revenue Share by Manufacturer (2019-2024)
3.3 Global Propofol Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Propofol Manufacturers Covered: Ranking by Revenue
3.4.2 Global Propofol Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Propofol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Propofol Manufacturing Base Distribution, Product Type
3.5.1 Propofol Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Propofol Product Type
3.5.3 Date of International Manufacturers Enter into Propofol Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bachem
4.1.1 Bachem Company Information
4.1.2 Bachem Description, Business Overview
4.1.3 Bachem Propofol Products Offered
4.1.4 Bachem Propofol Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Bachem Propofol Sales by Product in 2023
4.1.6 Bachem Propofol Sales by Application in 2023
4.1.7 Bachem Propofol Sales by Geographic Area in 2023
4.1.8 Bachem Recent Developments
4.2 Curia
4.2.1 Curia Company Information
4.2.2 Curia Description, Business Overview
4.2.3 Curia Propofol Products Offered
4.2.4 Curia Propofol Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Curia Propofol Sales by Product in 2023
4.2.6 Curia Propofol Sales by Application in 2023
4.2.7 Curia Propofol Sales by Geographic Area in 2023
4.2.8 Curia Recent Developments
4.3 SI Group
4.3.1 SI Group Company Information
4.3.2 SI Group Description, Business Overview
4.3.3 SI Group Propofol Products Offered
4.3.4 SI Group Propofol Sales, Revenue and Gross Margin (2019-2024)
4.3.5 SI Group Propofol Sales by Product in 2023
4.3.6 SI Group Propofol Sales by Application in 2023
4.3.7 SI Group Propofol Sales by Geographic Area in 2023
4.3.8 SI Group Recent Developments
4.4 Neuland Laboratories
4.4.1 Neuland Laboratories Company Information
4.4.2 Neuland Laboratories Description, Business Overview
4.4.3 Neuland Laboratories Propofol Products Offered
4.4.4 Neuland Laboratories Propofol Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Neuland Laboratories Propofol Sales by Product in 2023
4.4.6 Neuland Laboratories Propofol Sales by Application in 2023
4.4.7 Neuland Laboratories Propofol Sales by Geographic Area in 2023
4.4.8 Neuland Laboratories Recent Developments
4.5 Harman Finochem
4.5.1 Harman Finochem Company Information
4.5.2 Harman Finochem Description, Business Overview
4.5.3 Harman Finochem Propofol Products Offered
4.5.4 Harman Finochem Propofol Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Harman Finochem Propofol Sales by Product in 2023
4.5.6 Harman Finochem Propofol Sales by Application in 2023
4.5.7 Harman Finochem Propofol Sales by Geographic Area in 2023
4.5.8 Harman Finochem Recent Developments
4.6 Midas Pharma
4.6.1 Midas Pharma Company Information
4.6.2 Midas Pharma Description, Business Overview
4.6.3 Midas Pharma Propofol Products Offered
4.6.4 Midas Pharma Propofol Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Midas Pharma Propofol Sales by Product in 2023
4.6.6 Midas Pharma Propofol Sales by Application in 2023
4.6.7 Midas Pharma Propofol Sales by Geographic Area in 2023
4.6.8 Midas Pharma Recent Development
4.7 Guangdong Jiabo Pharmaceutical
4.7.1 Guangdong Jiabo Pharmaceutical Company Information
4.7.2 Guangdong Jiabo Pharmaceutical Description, Business Overview
4.7.3 Guangdong Jiabo Pharmaceutical Propofol Products Offered
4.7.4 Guangdong Jiabo Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Guangdong Jiabo Pharmaceutical Propofol Sales by Product in 2023
4.7.6 Guangdong Jiabo Pharmaceutical Propofol Sales by Application in 2023
4.7.7 Guangdong Jiabo Pharmaceutical Propofol Sales by Geographic Area in 2023
4.7.8 Guangdong Jiabo Pharmaceutical Recent Development
4.8 Sichuan Biokin Pharmaceutical
4.8.1 Sichuan Biokin Pharmaceutical Company Information
4.8.2 Sichuan Biokin Pharmaceutical Description, Business Overview
4.8.3 Sichuan Biokin Pharmaceutical Propofol Products Offered
4.8.4 Sichuan Biokin Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Sichuan Biokin Pharmaceutical Propofol Sales by Product in 2023
4.8.6 Sichuan Biokin Pharmaceutical Propofol Sales by Application in 2023
4.8.7 Sichuan Biokin Pharmaceutical Propofol Sales by Geographic Area in 2023
4.8.8 Sichuan Biokin Pharmaceutical Recent Development
4.9 Xi’an Libang Pharmaceutical
4.9.1 Xi’an Libang Pharmaceutical Company Information
4.9.2 Xi’an Libang Pharmaceutical Description, Business Overview
4.9.3 Xi’an Libang Pharmaceutical Propofol Products Offered
4.9.4 Xi’an Libang Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Xi’an Libang Pharmaceutical Propofol Sales by Product in 2023
4.9.6 Xi’an Libang Pharmaceutical Propofol Sales by Application in 2023
4.9.7 Xi’an Libang Pharmaceutical Propofol Sales by Geographic Area in 2023
4.9.8 Xi’an Libang Pharmaceutical Recent Development
4.10 Beijing Sciecure Pharmaceutical
4.10.1 Beijing Sciecure Pharmaceutical Company Information
4.10.2 Beijing Sciecure Pharmaceutical Description, Business Overview
4.10.3 Beijing Sciecure Pharmaceutical Propofol Products Offered
4.10.4 Beijing Sciecure Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
4.10.5 Beijing Sciecure Pharmaceutical Propofol Sales by Product in 2023
4.10.6 Beijing Sciecure Pharmaceutical Propofol Sales by Application in 2023
4.10.7 Beijing Sciecure Pharmaceutical Propofol Sales by Geographic Area in 2023
4.10.8 Beijing Sciecure Pharmaceutical Recent Development
4.11 Jiangsu Nhwa Pharmaceutical
4.11.1 Jiangsu Nhwa Pharmaceutical Company Information
4.11.2 Jiangsu Nhwa Pharmaceutical Description, Business Overview
4.11.3 Jiangsu Nhwa Pharmaceutical Propofol Products Offered
4.11.4 Jiangsu Nhwa Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
4.11.5 Jiangsu Nhwa Pharmaceutical Propofol Sales by Product in 2023
4.11.6 Jiangsu Nhwa Pharmaceutical Propofol Sales by Application in 2023
4.11.7 Jiangsu Nhwa Pharmaceutical Propofol Sales by Geographic Area in 2023
4.11.8 Jiangsu Nhwa Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Propofol Sales by Type (2019-2030)
5.1.1 Global Propofol Sales by Type (2019-2024)
5.1.2 Global Propofol Sales Forecast by Type (2025-2030)
5.1.3 Global Propofol Sales Market Share by Type (2019-2030)
5.2 Global Propofol Revenue Forecast by Type (2019-2030)
5.2.1 Global Propofol Revenue by Type (2019-2024)
5.2.2 Global Propofol Revenue Forecast by Type (2025-2030)
5.2.3 Global Propofol Revenue Market Share by Type (2019-2030)
5.3 Propofol Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Propofol Sales by Application (2019-2030)
6.1.1 Global Propofol Sales by Application (2019-2024)
6.1.2 Global Propofol Sales Forecast by Application (2025-2030)
6.1.3 Global Propofol Sales Market Share by Application (2019-2030)
6.2 Global Propofol Revenue Forecast by Application (2019-2030)
6.2.1 Global Propofol Revenue by Application (2019-2024)
6.2.2 Global Propofol Revenue Forecast by Application (2025-2030)
6.2.3 Global Propofol Revenue Market Share by Application (2019-2030)
6.3 Propofol Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Propofol Market Size YoY Growth 2019-2030
7.2 North America Propofol Market Facts & Figures by Country
7.2.1 North America Propofol Sales by Country (2019-2030)
7.2.2 North America Propofol Revenue by Country (2019-2030)
7.3 North America Propofol Sales by Type (2019-2024)
7.4 North America Propofol Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Propofol Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Propofol Market Facts & Figures by Region
8.2.1 Asia-Pacific Propofol Sales by Region (2019-2030)
8.2.2 Asia-Pacific Propofol Revenue by Region (2019-2030)
8.3 Asia-Pacific Propofol Sales by Type (2019-2024)
8.4 Asia-Pacific Propofol Sales by Application (2019-2024)
9 Europe
9.1 Europe Propofol Market Size YoY Growth 2019-2030
9.2 Europe Propofol Market Facts & Figures by Country
9.2.1 Europe Propofol Sales by Country (2019-2030)
9.2.2 Europe Propofol Revenue by Country (2019-2030)
9.3 Europe Propofol Sales by Type (2019-2024)
9.4 Europe Propofol Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Propofol Market Size YoY Growth 2019-2030
10.2 Latin America Propofol Market Facts & Figures by Country
10.2.1 Latin America Propofol Sales by Country (2019-2030)
10.2.2 Latin America Propofol Revenue by Country (2019-2030)
10.3 Latin America Propofol Sales by Type (2019-2024)
10.4 Latin America Propofol Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Propofol Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Propofol Market Facts & Figures by Country
11.2.1 Middle East and Africa Propofol Sales by Country (2019-2030)
11.2.2 Middle East and Africa Propofol Revenue by Country (2019-2030)
11.3 Middle East and Africa Propofol Sales by Type (2019-2024)
11.4 Middle East and Africa Propofol Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Propofol Supply Chain Analysis
12.2 Propofol Key Raw Materials and Upstream Suppliers
12.3 Propofol Clients Analysis
12.4 Propofol Sales Channel and Sales Model Analysis
12.4.1 Propofol Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Propofol Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Propofol Distributors
13 Market Dynamics
13.1 Propofol Industry Trends
13.2 Propofol Market Drivers
13.3 Propofol Market Challenges
13.4 Propofol Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer